Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4978)
All Articles published online
|
Jul 14, 2009 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G. Current management strategy of hepatocellular carcinoma. World J Gastroenterol 2009; 15(26): 3210-3216 [PMID: 19598295 DOI: 10.3748/wjg.15.3210] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i26/3210.htm |
| Number | Citing Articles |
| 1 |
Kyung Won Kim, Jeong Min Lee, Byung Ihn Choi. Assessment of the treatment response of HCC. Abdominal Imaging 2011; 36(3): 300 doi: 10.1007/s00261-011-9683-3
|
| 2 |
Shengnan Zhao, Aixia Chen, Jingyu Cao, Zusen Wang, Weiyu Hu, Fei Zhou, Donghai Liang, Hongsheng Yu. Neurotrophin 3 hinders the growth and metastasis of hepatocellular carcinoma cells*. Oncology and Translational Medicine 2020; 6(4): 143 doi: 10.1007/s10330-020-0426-6
|
| 3 |
A.C. Teixeira, Ê.D. Mente, O. Castro-e-Silva, A.K. Sankarankutty, C.A. Cantão, F.F. Souza, D. Abud, V. Muglia, J. Elias-Junior, A.L.C. Martinelli. Treatment of Hepatocellular Carcinoma With Liver Transplantation: A Single-Center Experience From Brazil. Transplantation Proceedings 2010; 42(2): 502 doi: 10.1016/j.transproceed.2010.01.045
|
| 4 |
Peramaiyan Rajendran, Tina H. Ong, Luxi Chen, Feng Li, Muthu K. Shanmugam, Shireen Vali, Taher Abbasi, Shweta Kapoor, Ashish Sharma, Alan Prem Kumar, Kam M. Hui, Gautam Sethi. Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo
. Clinical Cancer Research 2011; 17(6): 1425 doi: 10.1158/1078-0432.CCR-10-1123
|
| 5 |
Nima Kokabi, Juan C. Camacho, Minzhi Xing, Bassel F. El‐Rayes, James R. Spivey, Stuart J. Knechtle, Hyun S. Kim. Open‐label prospective study of the safety and efficacy of glass‐based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis. Cancer 2015; 121(13): 2164 doi: 10.1002/cncr.29275
|
| 6 |
Fei Zhao, Jin Zhao, Lei Song, Ya-Qing Zhang, Zhong Guo, Ke-Hu Yang. The induction of apoptosis and autophagy in human hepatoma SMMC-7721 cells by combined treatment with vitamin C and polysaccharides extracted from Grifola frondosa
. Apoptosis 2017; 22(11): 1461 doi: 10.1007/s10495-017-1421-z
|
| 7 |
BO TANG, JIAN DU, JINGWEN WANG, GUANG TAN, ZHENMING GAO, ZHONGYU WANG, LIMING WANG. Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium. Oncology Reports 2012; 27(4): 1090 doi: 10.3892/or.2011.1580
|
| 8 |
BIN HU, MING SUN, JIAJUN LIU, GUOLIN HONG, QIN LIN. The preventative effect of Akt knockout on liver cancer through modulating NF-κB-regulated inflammation and Bad-related apoptosis signaling pathway. International Journal of Oncology 2016; 48(4): 1467 doi: 10.3892/ijo.2016.3383
|
| 9 |
In Kyung Park, Jeong-Sik Yu, Eun-Suk Cho, Joo Hee Kim, Jae-Joon Chung. Pseudoglandular Formation in Hepatocellular Carcinoma Determines Apparent Diffusion Coefficient in Diffusion-Weighted MRI. Investigative Magnetic Resonance Imaging 2018; 22(2): 79 doi: 10.13104/imri.2018.22.2.79
|
| 10 |
Ji-Hua Shi, Henrik S. Huitfeldt, Zhen-He Suo, Pål-Dag Line. Growth of hepatocellular carcinoma in the regenerating liver. Liver Transplantation 2011; 17(7): 866 doi: 10.1002/lt.22325
|
| 11 |
Jing Cai, Qiang Xiong, Xiaoliu Jiang, Shan Zhou, Tiande Liu. RNF6 facilitates metastasis and radioresistance in hepatocellular carcinoma through ubiquitination of FoxA1. Experimental Cell Research 2019; 374(1): 152 doi: 10.1016/j.yexcr.2018.11.019
|
| 12 |
Chen‐Te Chou, Yao‐Li Chen, Wei‐Wen Su, Hwa‐Koon Wu, Ran‐Chou Chen. Characterization of cirrhotic nodules with gadoxetic acid‐enhanced magnetic resonance imaging: The efficacy of hepatocyte‐phase imaging. Journal of Magnetic Resonance Imaging 2010; 32(4): 895 doi: 10.1002/jmri.22316
|
| 13 |
Song Ye, Xin-Yi Zhao, Xiao-Ge Hu, Tang Li, Qiu-Ran Xu, Huan-Ming Yang, Dong-Sheng Huang, Liu Yang. TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma. Oncology Reports 2017; 37(4): 2215 doi: 10.3892/or.2017.5494
|
| 14 |
Yi‐ying Wu, Li‐hong Wan, Xiao‐wei Zheng, Zhen‐jun Shao, Jian Chen, Xia‐jing Chen, Li‐tao Liu, Wen‐juan Kuang, Xian‐shu Tan, Li‐ming Zhou. Inhibitory Effects of β,β‐Dimethylacrylshikonin on Hepatocellular Carcinoma In Vitro and In Vivo. Phytotherapy Research 2012; 26(5): 764 doi: 10.1002/ptr.3623
|
| 15 |
Clément Guillot, Janet Hall, Zdenko Herceg, Philippe Merle, Isabelle Chemin. Update on hepatocellular carcinoma breakthroughs: Poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy. Clinics and Research in Hepatology and Gastroenterology 2014; 38(2): 137 doi: 10.1016/j.clinre.2013.07.006
|
| 16 |
XU-ZHENG CHEN, JIN-NONG LI, YOU-QUAN ZHANG, ZHI-YUN CAO, ZHI-ZHEN LIU, SU-QING WANG, LIAN-MING LIAO, JIAN DU. Fuzheng Qingjie recipe induces apoptosis in HepG2 cells via P38 MAPK activation and the mitochondria-dependent apoptotic pathway. Molecular Medicine Reports 2014; 9(6): 2381 doi: 10.3892/mmr.2014.2138
|
| 17 |
T. Livraghi, H. Mäkisalo, P.-D. Line. Treatment Options in Hepatocellular Carcinoma Today. Scandinavian Journal of Surgery 2011; 100(1): 22 doi: 10.1177/145749691110000105
|
| 18 |
Yan Wen, Rui-Qiang Zhao, Yun-Kai Zhang, Pranav Gupta, Li-Xiang Fu, An-Zhou Tang, Bu-Ming Liu, Zhe-Sheng Chen, Dong-Hua Yang, Gang Liang. Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells. Oncotarget 2017; 8(18): 29760 doi: 10.18632/oncotarget.15964
|
| 19 |
Xiang-Feng Liu, Hai-Jiao Long, Xiong-Ying Miao, Guo-Li Liu, Hong-Liang Yao. Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor. Oncology Reports 2017; 38(1): 53 doi: 10.3892/or.2017.5676
|
| 20 |
Antoine Finianos, Charbel F. Matar, Ali Taher. Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis. International Journal of Molecular Sciences 2018; 19(12): 4070 doi: 10.3390/ijms19124070
|
| 21 |
P. Puneet, M. T. P. R. Perera, Darius F. Mirza. Current opinion on the role of resection and liver transplantation for hepatocellular cancer. Indian Journal of Gastroenterology 2012; 31(3): 89 doi: 10.1007/s12664-012-0200-6
|
| 22 |
V. Laurent, F. Legou, M. Pernin, A. Oliver, F. Jausset, G. Oldrini, P. Olivier, D. Peiffert. Imagerie Post-Thérapeutique en Oncologie. 2014; : 137 doi: 10.1016/B978-2-294-73840-1.00007-1
|
| 23 |
Mei Bai, Nancy R. Reynolds, Ruth McCorkle. The promise of clinical interventions for hepatocellular carcinoma from the west to mainland China. Palliative and Supportive Care 2013; 11(6): 503 doi: 10.1017/S1478951512001137
|
| 24 |
Masato Abei, Toshiyuki Okumura, Kuniaki Fukuda, Takayuki Hashimoto, Masahiro Araki, Kazunori Ishige, Ichinosuke Hyodo, Ayae Kanemoto, Haruko Numajiri, Masashi Mizumoto, Takeji Sakae, Hideyuki Sakurai, Junko Zenkoh, Gerelchuluun Ariungerel, Yu Sogo, Atsuo Ito, Tadao Ohno, Koji Tsuboi. A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma. Radiation Oncology 2013; 8(1) doi: 10.1186/1748-717X-8-239
|
| 25 |
Peng Qian, Yong-Wen Zhang, Zhong-Hai Zhou, Jun-Quan Liu, Su-Yang Yue, Xiang-Li Guo, Lei-Qing Sun, Xiao-Ting Lv, Jian-Qun Chen. Artesunate enhances γδ T-cell-mediated antitumor activity through augmenting γδ T-cell function and reversing immune escape of HepG2 cells. Immunopharmacology and Immunotoxicology 2018; 40(2): 107 doi: 10.1080/08923973.2017.1386212
|
| 26 |
Alain Braillon. Hepatocellular carcinoma and evidence-based surgery. World Journal of Gastroenterology 2009; 15(42): 5371-5371 doi: 10.3748/wjg.15.5371
|
| 27 |
Jeffery S. Russell, Rajiv Sawhney, Alexander Monto, Sujal Nanavati, J. Ben Davoren, Rizwan Aslam, Carlos U. Corvera. Periprocedural complications by Child-Pugh class in patients undergoing transcatheter arterial embolization or chemoembolization to treat unresectable hepatocellular carcinoma at a VA medical center. The American Journal of Surgery 2010; 200(5): 659 doi: 10.1016/j.amjsurg.2010.07.021
|
| 28 |
Ian M. Breunig, Fadia T. Shaya, Nader Hanna, Brian Seal, Viktor V. Chirikov, C. Daniel Mullins. Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival. Value in Health 2013; 16(5): 760 doi: 10.1016/j.jval.2013.03.1630
|
| 29 |
Feng Li, Prasana Priscilla Fernandez, Peramaiyan Rajendran, Kam M. Hui, Gautam Sethi. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Letters 2010; 292(2): 197 doi: 10.1016/j.canlet.2009.12.003
|
| 30 |
Zhan-Dong Hu, Ying Jiang, Hong-Mei Sun, Jing-wen Wang, Li-Li Zhai, Zhi-Qi Yin, Jun Yan, Marcello Maida. KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/2676745
|
| 31 |
Xiao-Fang Dai, Jie Ding, Rui-Guang Zhang, Jing-Hua Ren, C.-M. Charlie Ma, Gang Wu. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway. International Journal of Radiation Biology 2013; 89(9): 724 doi: 10.3109/09553002.2013.791405
|
| 32 |
Meng Gao, Hong Xu, Chenghong Zhang, Kexin Liu, Xu Bao, Qiuchen Chu, Yan He, Yan Tian. Preparation and characterization of curcumin thermosensitive hydrogels for intratumoral injection treatment. Drug Development and Industrial Pharmacy 2014; 40(11): 1557 doi: 10.3109/03639045.2013.838579
|
| 33 |
Rayan Bou-Fakhredin, Irene Motta, Maria Domenica Cappellini, Ali T. Taher. Clinical Complications and Their Management. Hematology/Oncology Clinics of North America 2023; 37(2): 365 doi: 10.1016/j.hoc.2022.12.007
|
| 34 |
Matthew W Lawless, Kenneth J O'Byrne, Steven G Gray. Targeting oxidative stress in cancer. Expert Opinion on Therapeutic Targets 2010; 14(11): 1225 doi: 10.1517/14728222.2010.526933
|
| 35 |
Gar-Yang Chau. Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome. World Journal of Gastroenterology 2014; 20(35): 12473-12484 doi: 10.3748/wjg.v20.i35.12473
|
| 36 |
M. Kondo, M. Morimoto, K. Numata, A. Nozaki, K. Tanaka. Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Japanese Journal of Clinical Oncology 2011; 41(1): 69 doi: 10.1093/jjco/hyq145
|
| 37 |
Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma. Bioorganic & Medicinal Chemistry Letters 2015; 25(4): 893 doi: 10.1016/j.bmcl.2014.12.065
|
| 38 |
Klaus J. Schmitz, Georgios C. Sotiropoulos, Hideo A. Baba, Kurt W. Schmid, Doris Müller, Andreas Paul, Thomas Auer, Gabriele Gamerith, Judith Loeffler-Ragg. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases. Liver International 2011; 31(6): 810 doi: 10.1111/j.1478-3231.2011.02511.x
|
| 39 |
Chen-Te Chou, Wen-Pei Wu, Chia-Bang Chen, Wei-Wen Su, Ran-Chou Chen, Yao-Li Chen, Erica Villa. The Utility of Gadoxetic Acid-Enhanced MR Imaging to Characterize Atypical Cirrhotic Nodules Detected on Dynamic CT Images. PLoS ONE 2014; 9(10): e107869 doi: 10.1371/journal.pone.0107869
|
| 40 |
A. Fassina. ‘The map is not the territory’: FNA the map and liver the territory. Cytopathology 2011; 22(5): 285 doi: 10.1111/j.1365-2303.2011.00928.x
|
| 41 |
Ji-Hua Shi, Pål-Dag Line. Effect of liver regeneration on malignant hepatic tumors. World Journal of Gastroenterology 2014; 20(43): 16167-16177 doi: 10.3748/wjg.v20.i43.16167
|
| 42 |
Wladimir Faber, Daniel Seehofer, Peter Neuhaus, Martin Stockmann, Timm Denecke, Sinan Kalmuk, Peter Warnick, Marcus Bahra. Repeated liver resection for recurrent hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2011; 26(7): 1189 doi: 10.1111/j.1440-1746.2011.06721.x
|
| 43 |
Wei‐Hsiang Lin, Shiou‐Hwei Yeh, Wan‐Jen Yang, Kun‐Huei Yeh, Toshiyoshi Fujiwara, Aisuke Nii, Stanley Shi‐Chung Chang, Pei‐Jer Chen. Telomerase‐specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice. International Journal of Cancer 2013; 132(6): 1451 doi: 10.1002/ijc.27770
|
| 44 |
Andrej Khandoga, Moritz Drefs, Markus Schoenberg, Tobias Schiergens, Katharina Frenes, Mark op den Winkel, Christoph Trumm, Martin K. Angele, Markus Guba, Jens Werner, Markus Rentsch. Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?. European Journal of Gastroenterology & Hepatology 2017; 29(9): 1045 doi: 10.1097/MEG.0000000000000912
|
| 45 |
BO TANG, ZHIGAO HU, YANG LI, SHENGGUANG YUAN, ZHENRAN WANG, SHUIPING YU, SONGQING HE. Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU. Molecular Medicine Reports 2016; 13(1): 59 doi: 10.3892/mmr.2015.4511
|
| 46 |
Nima Kokabi, Minzhi Xing, Richard Duszak, David H Howard, Kimberly E Applegate, Juan C Camacho, Hyun S Kim. Sociodemographic Impact on Survival in Unresectable Hepatocellular Carcinoma: A Survival Epidemiology and end Results Study. Future Oncology 2016; 12(2): 183 doi: 10.2217/fon.15.242
|
| 47 |
Zhuhong Zhang, Jing Yin, Chunyan Zhang, Ning Liang, Nan Bai, Antao Chang, Yanhua Liu, Zongjin Li, Xiaoyue Tan, Na Li, Dan Lv, Rong Xiang, Yaping Tian, Chenghu Liu. Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma. Cancer Biology & Therapy 2012; 13(6): 435 doi: 10.4161/cbt.19295
|
| 48 |
LEI HE, HAN-XIAN GONG, XIANG-PEN LI, YI-DONG WANG, YI LI, JUN-JIAN HUANG, DAN XIE, HSIANG-FU KUNG, YING PENG. Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice. Oncology Letters 2013; 6(3): 748 doi: 10.3892/ol.2013.1470
|
| 49 |
Xian-Jie Shi, Xin Jin, Mao-Qiang Wang, Li-Xin Wei, Hui-Yi Ye, Yu-Rong Liang, Ying Luo, Jia-Hong Dong. Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation. Hepatobiliary & Pancreatic Diseases International 2011; 10(2): 143 doi: 10.1016/S1499-3872(11)60023-4
|
| 50 |
Minzhi Xing, Grant Webber, Hasmukh J Prajapati, Zhengjia Chen, Bassel El‐Rayes, James R Spivey, Anjana A Pillai, Hyun S Kim. Preservation of quality of life with doxorubicin drug‐eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study. Journal of Gastroenterology and Hepatology 2015; 30(7): 1167 doi: 10.1111/jgh.12920
|
| 51 |
Yang Cheng, Baobing Yin, Tianlu Hou, Tianyang Chen, Jian Ping. The overexpression of GRASP might inhibit cell proliferation and invasion in hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(9): 16215 doi: 10.1002/jcp.28285
|
| 52 |
SER YEE LEE, MICHAEL D. KLUGER, DANIEL CHERQUI. Clinical Interventional Oncology. 2014; : 65 doi: 10.1016/B978-1-4557-1221-2.00016-7
|
| 53 |
Hassan M. Moukhadder, Racha Halawi, Maria Domenica Cappellini, Ali T. Taher. Reply to Management of hepatocellular carcinoma in thalassemia and importance of the human factor. Cancer 2017; 123(6): 1073 doi: 10.1002/cncr.30550
|
| 54 |
Yee-Jee Jan, Bor-Sheng Ko, Tzu-An Liu, Yao-Ming Wu, Shu-Man Liang, Shyh-Chang Chen, John Wang, Jun-Yang Liou. Expression of Partitioning Defective 3 (Par-3) for Predicting Extrahepatic Metastasis and Survival with Hepatocellular Carcinoma. International Journal of Molecular Sciences 2013; 14(1): 1684 doi: 10.3390/ijms14011684
|
| 55 |
Hai Ha Thi Pham, Yeong-Ae Seong, Chul-Woong Oh, Gun-Do Kim. The herbal medicine Cyperus amuricus inhibits proliferation of human hepatocellular carcinoma Hep3B cells by inducing apoptosis and arrest at the G0/G1 cell cycle phase. International Journal of Oncology 2016; 49(5): 2046 doi: 10.3892/ijo.2016.3698
|
| 56 |
Nikki P. Lee, Ronnie T.P. Poon, Felix H. Shek, Irene O.L. Ng, John M. Luk. Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2010; 1806(2): 138 doi: 10.1016/j.bbcan.2010.05.002
|
| 57 |
Christoph Roderburg, Jhenee Bubenzer, Michael Spannbauer, Nicole do O, Andreas Mahnken, Tom Ludde, Christian Trautwein, Jens J Tischendorf. Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib. World Journal of Hepatology 2010; 2(6): 239-242 doi: 10.4254/wjh.v2.i6.239
|
| 58 |
Naokazu Chiba, Yosuke Ozawa, Kosuke Hikita, Masaaki Okihara, Toru Sano, Koichi Tomita, Kiminori Takano, Shigeyuki Kawachi. Increased expression of HOXB9 in hepatocellular carcinoma predicts poor overall survival but a beneficial response to sorafenib. Oncology Reports 2017; 37(4): 2270 doi: 10.3892/or.2017.5474
|
| 59 |
Jürgen S. Scheele, Jan Harder, Zoran Stankovic, Daniel Räpple, Annette Dorn, Hans C. Spangenberg, Hubert E. Blum. Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report. Journal of Medical Case Reports 2011; 5(1) doi: 10.1186/1752-1947-5-478
|
| 60 |
Sung Hoon Kim, Kyoung Sook Won, Byung Wook Choi, Il Jo, Seok Kil Zeon, Woo Jin Chung, Jung Hyeok Kwon. Usefulness of F-18 FDG PET/CT in the Evaluation of Early Treatment Response After Interventional Therapy for Hepatocellular Carcinoma. Nuclear Medicine and Molecular Imaging 2012; 46(2): 102 doi: 10.1007/s13139-012-0138-8
|
| 61 |
Hung‐Wen Tsai, Yih‐Jyh Lin, Pin‐Wen Lin, Han‐Chieh Wu, Kai‐Hsi Hsu, Chia‐Jui Yen, Shih‐Huang Chan, Wenya Huang, Ih‐Jen Su. A clustered ground‐glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery. Cancer 2011; 117(13): 2951 doi: 10.1002/cncr.25837
|
| 62 |
Qi Zhang, Xue Li Bai, Wei Chen, Tao Ma, Hao Liu, Yun Zhang, Xiao Jun Hu, Ting Bo Liang. Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD010897
|
| 63 |
Nima Kokabi, Richard Duszak, Minzhi Xing, David H Howard, Kimberly E Applegate, Juan C Camacho, Hyun S Kim. Cancer-directed therapy and potential impact on survivals in nonresected hepatocellular carcinoma: SEER-Medicare population study. Future Oncology 2017; 13(23): 2021 doi: 10.2217/fon-2017-0116
|
| 64 |
Jean-Marc Idée, Boris Guiu. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A review. Critical Reviews in Oncology/Hematology 2013; 88(3): 530 doi: 10.1016/j.critrevonc.2013.07.003
|
| 65 |
Iván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, David Medina-Preciado, Juan Armendáriz-Borunda. Adenoviral gene therapy in hepatocellular carcinoma: a review. Hepatology International 2013; 7(1): 48 doi: 10.1007/s12072-012-9367-2
|
| 66 |
Lian-Hua Cui, Xiao-Wen Xu, Zhen-Yu Quan. Influence of MTHFR 1298A→C polymorphism on response to transarterial chemoembolization in primary hepatocellular carcinoma: A pilot study. Proceedings 2011 International Conference on Human Health and Biomedical Engineering 2011; : 602 doi: 10.1109/HHBE.2011.6028384
|
| 67 |
Jia-Yuan Huang, Kai Zhang, Dong-Qin Chen, Jing Chen, Bing Feng, Haizhu Song, Yitian Chen, Ziman Zhu, Lei Lu, Wei De, Rui Wang, Long-Bang Chen. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Oncotarget 2015; 6(21): 18613 doi: 10.18632/oncotarget.4317
|
| 68 |
Gautam Sethi, Snehajyoti Chatterjee, Peramaiyan Rajendran, Feng Li, Muthu K Shanmugam, Kwong Fai Wong, Alan Prem Kumar, Parijat Senapati, Amit K Behera, Kam Man Hui, Jeelan Basha, Nagashayana Natesh, John M Luk, Tapas K Kundu. Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Molecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-66
|
| 69 |
XUE-QIN MENG, WEI ZHANG, FENG ZHANG, SHENG-YONG YIN, HAI-YANG XIE, LIN ZHOU, SHU-SEN ZHENG. Solanine-induced reactive oxygen species inhibit the growth of human hepatocellular carcinoma HepG2 cells. Oncology Letters 2016; 11(3): 2145 doi: 10.3892/ol.2016.4167
|
| 70 |
Shizhong Yang, Yanfeng Liu, Xiaobin Feng, Xiaojuan Wang, Meilong Wu, Lei Gong, Bin Shu, Qian lu, Jiahong Dong. HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro. Digestive and Liver Disease 2021; 53(3): 360 doi: 10.1016/j.dld.2020.10.007
|
| 71 |
Peramaiyan Rajendran, Feng Li, Kanjoormana Aryan Manu, Muthu K. Shanmugam, Ser Yue Loo, Alan Prem Kumar, Gautam Sethi. γ‐Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro‐apoptotic and chemosensitizing agent. British Journal of Pharmacology 2011; 163(2): 283 doi: 10.1111/j.1476-5381.2010.01187.x
|
| 72 |
Koichi Nonaka, Shinya Onizuka, Hiromi Ishibashi, Yoshihiro Uto, Hitoshi Hori, Toshiyuki Nakayama, Nariaki Matsuura, Takashi Kanematsu, Hikaru Fujioka. Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice. Journal of Surgical Research 2012; 172(1): 116 doi: 10.1016/j.jss.2010.07.057
|
| 73 |
JIN LU, ZEFENG LIU, LINGLING ZHAO, HUIMIN TIAN, XIUHUA LIU, CHANGJI YUAN. In vivo and in vitro inhibition of human liver cancer progress by downregulation of the μ-opioid receptor and relevant mechanisms. Oncology Reports 2013; 30(4): 1731 doi: 10.3892/or.2013.2640
|
| 74 |
Peramaiyan Rajendran, Feng Li, Muthu K. Shanmugam, Radhamani Kannaiyan, Jen Nee Goh, Kwong Fai Wong, Wei Wang, Ester Khin, Vinay Tergaonkar, Alan Prem Kumar, John M. Luk, Gautam Sethi. Celastrol Suppresses Growth and Induces Apoptosis of Human Hepatocellular Carcinoma through the Modulation of STAT3/JAK2 Signaling Cascade In Vitro and In Vivo
. Cancer Prevention Research 2012; 5(4): 631 doi: 10.1158/1940-6207.CAPR-11-0420
|
| 75 |
Hassan M. Moukhadder, Racha Halawi, Maria Domenica Cappellini, Ali T. Taher. Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review. Cancer 2017; 123(5): 751 doi: 10.1002/cncr.30462
|
| 76 |
Meng Wang, Kai Wei, Baifeng Qian, Svenja Feiler, Anastasia Lemekhova, Markus W. Büchler, Katrin Hoffmann. HSP70–eIF4G Interaction Promotes Protein Synthesis and Cell Proliferation in Hepatocellular Carcinoma. Cancers 2020; 12(8): 2262 doi: 10.3390/cancers12082262
|
| 77 |
ASAF TAGHIYEV, DEGUANG SUN, ZHEN MING GAO, RUI LIANG, LIMING WANG. Embelin-induced apoptosis of HepG2 human hepatocellular carcinoma cells and blockade of HepG2 cells in the G2/M phase via the mitochondrial pathway. Experimental and Therapeutic Medicine 2012; 4(4): 649 doi: 10.3892/etm.2012.637
|
| 78 |
Shukui Qin, Yuxian Bai, Ho Yeong Lim, Sumitra Thongprasert, Yee Chao, Jia Fan, Tsai-Shen Yang, Vajarabhongsa Bhudhisawasdi, Won Ki Kang, Yu Zhou, Jee Hyun Lee, Yan Sun. Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia. Journal of Clinical Oncology 2013; 31(28): 3501 doi: 10.1200/JCO.2012.44.5643
|
| 79 |
Chunsun Li, Miaomiao Wu, Guijuan Zong, Chunhua Wan, Qingqing Liu, Huiling Zhou, Lu Hua, Yuyan Chen, Xudong Chen, Cuihua Lu. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Digestive Diseases and Sciences 2017; 62(1): 133 doi: 10.1007/s10620-016-4365-1
|
| 80 |
János Fehér, Gabriella Lengyel. Hepatocellular carcinoma: occurrence, risk factors, biomarkers. Orvosi Hetilap 2010; 151(23): 933 doi: 10.1556/oh.2010.28900
|
| 81 |
Jian-Jun Li, Jia-Sheng Zheng, Shi-Chang Cui, Xiong-Wei Cui, Cai-Xia Hu, Da Fang, Lin-Chao Ye. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(10): 3035-3040 doi: 10.3748/wjg.v21.i10.3035
|
| 82 |
Hesham Hazin, David Dosik. An Information Technology Framework for Predictive, Preventive and Personalised Medicine. Advances in Predictive, Preventive and Personalised Medicine 2015; 8: 53 doi: 10.1007/978-3-319-12166-6_6
|
| 83 |
Junyan Tao, Junfang Ji, Xiaolei Li, Ning Ding, Heng Wu, Yan Liu, XinWei Wang, Diego F. Calvisi, Guisheng Song, Xin Chen. Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer. Oncotarget 2015; 6(9): 6977 doi: 10.18632/oncotarget.3166
|
| 84 |
Tzu-An Liu, Yee-Jee Jan, Bor-Sheng Ko, Shyh-Chang Chen, Shu-Man Liang, Ya-Lin Hung, Chiun Hsu, Tang-Long Shen, Yen-Ming Lee, Pei-Feng Chen, John Wang, Song-Kun Shyue, Jun-Yang Liou. Increased Expression of 14-3-3β Promotes Tumor Progression and Predicts Extrahepatic Metastasis and Worse Survival in Hepatocellular Carcinoma. The American Journal of Pathology 2011; 179(6): 2698 doi: 10.1016/j.ajpath.2011.08.010
|
| 85 |
Andrea Mancuso. Hepatocellular carcinoma in thalassemia: A critical review. World Journal of Hepatology 2010; 2(5): 171-174 doi: 10.4254/wjh.v2.i5.171
|
| 86 |
Zhitao Zhou, Xiao Lu, Ping Zhu, Wei Zhu, Xia Mu, Rongmei Qu, Ming Li. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells. Biochemical and Biophysical Research Communications 2012; 420(2): 336 doi: 10.1016/j.bbrc.2012.02.160
|
| 87 |
Yan Zhou, Ping He, Xuhua Xie, Changyu Sun. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma. Molecular and Cellular Biochemistry 2019; 450(1-2): 125 doi: 10.1007/s11010-018-3379-8
|
| 88 |
Xiao-Dong Wang, Ren-Jie Yang, Xi-Cai Cao, Jian Tan, Bin Li. Dose Delivery Estimated by Bremsstrahlung Imaging and Partition Model Correlated with Response Following Intra-arterial Radioembolization with 32P-Glass Microspheres for the Treatment of Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2010; 14(5): 858 doi: 10.1007/s11605-010-1180-4
|
| 89 |
Wei-xun Chen, Zhan-guo Zhang, Ze-yang Ding, Hui-fang Liang, Jia Song, Xiao-long Tan, Jing-jing Wu, Guang-zhen Li, Zhuo Zeng, Bi-xiang Zhang, Xiao-ping Chen. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma. Oncotarget 2016; 7(16): 22674 doi: 10.18632/oncotarget.8047
|
| 90 |
Francesca Ponziani, Veronica Ojetti, Annalisa Tortora, Luca Di Maurizio, Flaminia Purchiaroni, Antonio Gasbarrini. The metabolic and toxicological considerations for mTOR inhibitors in the treatment of hepatocarcinoma. Expert Opinion on Drug Metabolism & Toxicology 2011; 7(12): 1535 doi: 10.1517/17425255.2011.631911
|
| 91 |
Samar S. Azab, Mohamed Abdel-Daim, Omayma A. Eldahshan. Phytochemical, cytotoxic, hepatoprotective and antioxidant properties of Delonix regia leaves extract. Medicinal Chemistry Research 2013; 22(9): 4269 doi: 10.1007/s00044-012-0420-4
|
| 92 |
Xiangyu Chen, Enhua Xiao, Dianshuang Shu, Chengzhi Yang, Bin Liang, Zhong He, Dujun Bian. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging. European Journal of Gastroenterology & Hepatology 2014; 26(1): 109 doi: 10.1097/MEG.0b013e328363716e
|
| 93 |
Jen-Jie Lin, Robert Wang, Jiing-Chuan Chen, Chien-Chih Chiu, Ming-Hui Liao, Yu-Jen Wu. Cytotoxicity of 11-epi-Sinulariolide Acetate Isolated from Cultured Soft Corals on HA22T Cells through the Endoplasmic Reticulum Stress Pathway and Mitochondrial Dysfunction. International Journal of Molecular Sciences 2016; 17(11): 1787 doi: 10.3390/ijms17111787
|
| 94 |
Andreea Cioca, Anca Cimpean, Raluca Ceausu, Ana-Maria Fit, Teodor Zaharie, Nadim Al-Hajjar, Vlad Puia, Marius Raica. Crosstalk between EGFR and p53 in Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2014; 15(19): 8069 doi: 10.7314/APJCP.2014.15.19.8069
|
| 95 |
BO TANG, YANG LI, SHENGGUANG YUAN, STEPHEN TOMLINSON, SONGQING HE. Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo. International Journal of Oncology 2013; 43(4): 1281 doi: 10.3892/ijo.2013.2046
|
| 96 |
TV Ajithkumar, E de Winton. Specialist Training in Oncology. 2011; : 134 doi: 10.1016/B978-0-7234-3458-0.00016-6
|